DK0983058T3 - Medicinske aerosolprodukter - Google Patents

Medicinske aerosolprodukter

Info

Publication number
DK0983058T3
DK0983058T3 DK98922409T DK98922409T DK0983058T3 DK 0983058 T3 DK0983058 T3 DK 0983058T3 DK 98922409 T DK98922409 T DK 98922409T DK 98922409 T DK98922409 T DK 98922409T DK 0983058 T3 DK0983058 T3 DK 0983058T3
Authority
DK
Denmark
Prior art keywords
ciclesonide
butyl
formulations
aerosol products
medical aerosol
Prior art date
Application number
DK98922409T
Other languages
English (en)
Inventor
Martin J Oliver
Kanu M Fatania
John S Scott
Helgert Muller
Original Assignee
Altana Pharma Ag
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26311564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0983058(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9710496.2A external-priority patent/GB9710496D0/en
Priority claimed from GBGB9803990.2A external-priority patent/GB9803990D0/en
Application filed by Altana Pharma Ag, Minnesota Mining & Mfg filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0983058T3 publication Critical patent/DK0983058T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Materials For Medical Uses (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Steroid Compounds (AREA)
DK98922409T 1997-05-21 1998-05-18 Medicinske aerosolprodukter DK0983058T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710496.2A GB9710496D0 (en) 1997-05-21 1997-05-21 Medicinal aerosol products
GBGB9803990.2A GB9803990D0 (en) 1998-02-25 1998-02-25 Medicinal aerosol products
PCT/US1998/010155 WO1998052542A1 (en) 1997-05-21 1998-05-18 Medicinal aerosol products

Publications (1)

Publication Number Publication Date
DK0983058T3 true DK0983058T3 (da) 2003-11-24

Family

ID=26311564

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98922409T DK0983058T3 (da) 1997-05-21 1998-05-18 Medicinske aerosolprodukter

Country Status (27)

Country Link
US (1) US6120752A (da)
EP (1) EP0983058B1 (da)
JP (4) JP2001526685A (da)
KR (1) KR100527643B1 (da)
CN (1) CN1149073C (da)
AT (1) ATE245966T1 (da)
AU (1) AU726835B2 (da)
BG (1) BG64268B1 (da)
BR (1) BR9809448A (da)
CA (1) CA2290521C (da)
CZ (1) CZ298253B6 (da)
DE (1) DE69816811T2 (da)
DK (1) DK0983058T3 (da)
EA (1) EA002381B1 (da)
ES (1) ES2205491T3 (da)
HU (1) HU226694B1 (da)
IL (1) IL132738A (da)
ME (1) ME01631B (da)
NO (2) NO327716B1 (da)
NZ (1) NZ500874A (da)
PL (1) PL191523B1 (da)
PT (1) PT983058E (da)
RS (1) RS49628B (da)
SK (1) SK283930B6 (da)
TR (1) TR199902863T2 (da)
UA (1) UA58551C2 (da)
WO (1) WO1998052542A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US20040235811A1 (en) * 2002-10-08 2004-11-25 Sepracor Inc. Fatty acid modified forms of glucocorticoids
PT2277972T (pt) * 2002-10-25 2019-06-11 Honeywell Int Inc Composições contendo olefinas substituídas por flúor
ES2312844T3 (es) * 2002-12-12 2009-03-01 Nycomed Gmbh Medicamento de combinacion de r, r-formoterol y ciclesonida.
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
AU2004246819A1 (en) 2003-06-13 2004-12-23 Nycomed Gmbh Formoterol and ciclesonide combination
WO2005025578A1 (en) * 2003-09-16 2005-03-24 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
GB2406283B (en) 2003-09-24 2006-04-05 Altana Pharma Ag Compliance monitor and method
US9308199B2 (en) 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20050153946A1 (en) * 2003-12-24 2005-07-14 Collegium Pharmaceuticals, Inc. Temperature-stable formulations, and methods of development thereof
JP2007533706A (ja) * 2004-04-20 2007-11-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 喫煙患者における呼吸器疾患の治療のためのシクレソニドの使用
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
WO2007068007A1 (en) * 2005-12-07 2007-06-14 Harm Benjamin Steyn Use of a disinfectant for treating respiratory tract infections
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
US20100120737A1 (en) * 2008-11-10 2010-05-13 Martin Feth Amorphous ciclesonide
ES2471145T3 (es) * 2009-03-09 2014-06-25 Mikasa Seiyaku Co,. Ltd. Compuesto esteroide
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
KR20180028563A (ko) * 2010-10-12 2018-03-16 시플라 리미티드 약학 조성물
WO2013024070A1 (en) 2011-08-18 2013-02-21 Nycomed Gmbh Pharmaceutical aerosol product for administration by oral or nasal inhalation
CN102335132A (zh) * 2011-10-12 2012-02-01 中山大学 一种细辛脑吸入气雾剂及其制备方法
WO2013114371A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dry powder formulations of dnase i
WO2013132497A1 (en) 2012-03-07 2013-09-12 Advanced Inhilation Therapies (Ait) Ltd. Inhalation of nitric oxide for treating respiratory diseases
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2077229B (en) * 1980-05-16 1983-08-03 Neotechnic Eng Ltd Valve assembly for a pressurized aerosoldispensing container
GB8824804D0 (en) * 1988-10-22 1988-11-30 Fisons Plc Device
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
JPH05505824A (ja) * 1990-03-23 1993-08-26 ミネソタ マイニング アンド マニュファクチャリング カンパニー 所定投与量エアロゾル製剤の製造のための可溶性弗素界面活性剤の使用
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
ATE114112T1 (de) * 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
EP0735884B1 (en) * 1993-12-20 2000-04-26 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
US5653961A (en) * 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
EP1366777B1 (en) * 1995-04-14 2005-06-15 SmithKline Beecham Corporation Metered dose inhaler for salmeterol
CA2218179A1 (en) * 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for beclomethasone dipropionate
DE69622166T2 (de) * 1995-04-14 2003-04-03 Smithkline Beecham Corp., Philadelphia Dosierinhalator für albuterol

Also Published As

Publication number Publication date
SK283930B6 (sk) 2004-05-04
KR20010012810A (ko) 2001-02-26
JP2016169222A (ja) 2016-09-23
RS49628B (sr) 2007-08-03
PL336885A1 (en) 2000-07-17
SK157699A3 (en) 2000-05-16
EP0983058B1 (en) 2003-07-30
CN1149073C (zh) 2004-05-12
UA58551C2 (uk) 2003-08-15
BR9809448A (pt) 2000-06-20
PT983058E (pt) 2003-12-31
HK1027027A1 (en) 2001-01-05
CN1257421A (zh) 2000-06-21
NZ500874A (en) 2001-09-28
CZ298253B6 (cs) 2007-08-08
JP2011102301A (ja) 2011-05-26
CA2290521C (en) 2006-10-10
BG64268B1 (bg) 2004-08-31
JP2015024999A (ja) 2015-02-05
NO2009024I2 (no) 2010-08-16
JP6178459B2 (ja) 2017-08-09
NO327716B1 (no) 2009-09-14
AU726835B2 (en) 2000-11-23
JP6087882B2 (ja) 2017-03-01
ES2205491T3 (es) 2004-05-01
BG103902A (en) 2000-05-31
HUP0002691A2 (hu) 2001-02-28
CZ412499A3 (cs) 2000-02-16
NO995667L (no) 1999-11-18
ME01631B (me) 2007-08-03
IL132738A0 (en) 2001-03-19
US6120752A (en) 2000-09-19
JP2001526685A (ja) 2001-12-18
EA002381B1 (ru) 2002-04-25
NO995667D0 (no) 1999-11-18
EP0983058A1 (en) 2000-03-08
IL132738A (en) 2004-06-20
WO1998052542A1 (en) 1998-11-26
TR199902863T2 (xx) 2000-05-22
AU7496298A (en) 1998-12-11
CA2290521A1 (en) 1998-11-26
ATE245966T1 (de) 2003-08-15
HUP0002691A3 (en) 2001-04-28
PL191523B1 (pl) 2006-06-30
EA199900991A1 (ru) 2000-08-28
KR100527643B1 (ko) 2005-11-15
HU226694B1 (en) 2009-06-29
DE69816811D1 (de) 2003-09-04
NO2009024I1 (no) 2009-10-26
YU59899A (sh) 2002-06-19
DE69816811T2 (de) 2004-04-15

Similar Documents

Publication Publication Date Title
NO995667D0 (no) Medisinske aerosolprodukter
DE60126599D1 (de) Cannabis enthaltende pharmazeutische zusammensetzungen
ATE401056T1 (de) Formoterol und ciclesonid aerosol-formulierungen
DK1303258T3 (da) Hidtil ukendte aerosolformuleringer, der indeholder et polært, floureret molekyle
BR9916829A (pt) Formulações aerossóis farmacêuticas contendo fluoroalcanos, budesonida e formoterol
NZ240237A (en) An aerosol formulation (free of surfactant) for treatment of asthma comprising: a hydrofluorocarbon propellant, ethanol, and beclomethasone 17,21 dipropionate; preparation thereof
HUP0102102A2 (hu) Pirazolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
CL2004001325A1 (es) Una composicion farmaceutica de aerosol que comprende cilesonida solubilizada en un propelente hidrofluorocarbono y un co-solvente, de preferencia etanol, util como antiinflamatorio de las vias aereas.
HUP9900849A2 (hu) Eljárás danazol által kiváltott csonttömegvesztés minimalizálására alkalmas gyógyszerkészítmények előállítása
HUP0001773A2 (hu) Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
HUP0004701A2 (hu) Új dezloratadin sók, az ezeket tartalmazó gyógyászati készítmények és eljárás azok előállítására
ATE184875T1 (de) Imidazo(1,2-a>indeno(1,2-e>pyrazin-2-carbonsäur derivate, ihre herstellung und sie enthaltende arzneimittel
JPS6322011A (ja) 口腔用衛生組成物
JPH0977640A (ja) 発毛・育毛料
JPS63264522A (ja) 消炎鎮痛剤用エアゾ−ル組成物
TH59375A3 (th) สูตรผสมทางเภสัช ที่ซึ่งการปลดปล่อยออกได้ถูกควบคุม
TH28989B (th) เททราไซคลิค ไทรเทอร์ปีน